Jim McDermott: “Prescription drug prices are out of control and the pharmaceutical industry is reaping the benefits.”

In my opinion, it could be one of the most important hearings we have held during my time as ranking member on the subcommittee.

We are trying to figure out where we are going as a country and how we can turn our investments and innovation into sustainable models moving forward.

This committee has the potential of doing more good for the American people than perhaps any other single subcommittee in the Congress.

It has been a pleasure serving on this committee.